Neoadjuvant Therapy of DOF Regimen Plus Bevacizumab Can Increase Surgical Resection Ratein Locally Advanced Gastric Cancer
Junxun Ma(Chinese People's Liberation Army), Nan Du(Chinese PLA General Hospital), Huanrong Kang(Chinese PLA General Hospital), Sheng Yao(BioReliance (United States)), Fangfang Yao(Wuhan University of Technology), Xiaosong Li(Soochow University)
Cited by 42
Related Papers
Recent global decline in endorheic basin water storages
|Nature Geoscience|2018|475
Safety, efficacy and tumor mutational burden as a biomarker of overall survival benefit in chemo-refractory gastric cancer treated with toripalimab, a PD-1 antibody in phase Ib/II clinical trial NCT02915432
|Annals of Oncology|2019|475
Satellites reveal widespread decline in global lake water storage
|Science|2023|462